Inizio appoints Oisín Ó Gógáin as Chief People Officer
November 3, 2026 | Pharma, healthcare
Inizio has appointed Oisín Ó Gógáin as Chief People Officer.
Based at Inizio’s Dublin headquarters, Oisín joins from Aon, where he was most recently Chief People Officer for the subregion of UK, Ireland, and South Africa, supporting around 10,000 colleagues. Over 14 years with the firm he held senior HR and Chief People Officer roles across Europe – with a particular focus on the Nordic region – as well as having spent time working in the US.
Oisín brings deep experience in building inclusive, values-led cultures that strengthen client focus and colleague engagement. He has led complex organizational change, including acquisitions and integrations, tech-enabled transformation, developing leadership capability, and building sustainable talent pipelines at scale.
Read the full article here.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Inizio appoints Oisín Ó Gógáin as Chief People Officer
Inizio has appointed Oisín Ó Gógáin as Chief People Officer.
Pharma leadership strategies for talent, AI adoption, and continuous learning
In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to augment the workforce, encourage continuous…
Smarter science, sharper strategy: Expert insights from ASCO® 2026
As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?
Intelligent Commercialization™ across the pharma lifecycle
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.
Four steps to a smarter congress strategy: A practical guidebook
This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.
Infographic: Are data blind spots putting your launch at risk?
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…
Key takeaways from ASCO® 2026
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…